Loading clinical trials...
Loading clinical trials...
A Novel Approach to Infantile Spasms: Combined Cosyntropin Injectable Suspension, 1 mg/mL and Vigabatrin Induction Therapy
Conditions
Interventions
Cosyntropin Injectable Suspension, 1 mg/mL
Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
+1 more
Locations
14
United States
Children's Hospital Los Angeles
Los Angeles, California, United States
UCSF Medical Center
San Francisco, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Children's Healthcare of Atlanta at Scottish Rite
Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Start Date
April 19, 2018
Primary Completion Date
June 1, 2021
Completion Date
August 1, 2021
Last Updated
May 27, 2021
NCT06315829
NCT03976076
NCT00441896
NCT01828437
NCT02885389
NCT01073579
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions